Chris Tovey, CEO of Destiny Pharma: Destiny is a bit of a unicorn in the UK

Episode 1639,   Sep 28, 2023, 06:01 AM

Headliner
Share
Subscribe
Chris Tovey, newly appointed CEO in his first interview suggests Destiny Pharma #DEST is a bit of a unicorn in the UK as there aren’t that many UK biotech companies which have the same near term potential.
Share
Subscribe
Next
Ian James of Silver Bullet: 4D AI contextual data platform, has delivered exceptional growth with revenues growing by 122%
Top episodes
Is a house price crash coming?
by The Vox Markets Podcast
Alastair Smith of Avacta: Successful Completion of Fourth Dose Escalation in AVA6000 Study
by The Vox Markets Podcast
Vox Markets Interview with Avacta CEO Alastair Smith
by The Vox Markets Podcast
Related episodes
"The Incident" of 1641 and Charles I's Failed Plot: Colleague Jonathan Healey narrates "The Incident" of 1641, a failed plot by Charles I to arrest Scottish Covenanter leaders, explaining that the conspiracy's exposure and Charles's subsequent denial dest
by The John Batchelor Show
GALÍPOLO NO BC no TerraçoCast #441
by Terraço Econômico
Another Company Delists and It Won't Be the Last!
by The SharePickers Podcast with Justin Waite